Masimo Corp
MASI165.070USD
+4.109+2.55%
Horarios del mercado （ET）Cotizaciones retrasadas 15 min
8.85BCap. mercado
PérdidaP/E TTM
Más Datos de Masimo Corp Compañía
Masimo Corporation is a global technology company that develops and produces a range of monitoring technologies, including measurements, sensors, patient monitors, and automation and connectivity solutions. The Company's segments include Healthcare and Non-healthcare. Its Healthcare segment develops, manufactures and markets a variety of noninvasive patient monitoring technologies, hospital automation and connectivity solutions, remote monitoring devices and consumer health products. The Company's measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry and advanced rainbow Pulse CO-Oximetry parameters. The Company's Non-healthcare business develops, manufactures, markets, sells home sound integration technologies and accessories, along with licensing complete high performance in-vehicle audio systems under consumer brands, such as Bowers & Wilkins, Denon, Marantz, HEOS, Classe, Polk Audio, Boston Acoustics, and Definitive Technology.
Información de la empresa
Código de la empresaMASI
Nombre de la empresaMasimo Corp
Fecha de salida a bolsaAug 08, 2007
Fundada en1996
Director ejecutivoMs. Catherine M. (Katie) Szyman
Número de empleados3600
Tipo de seguridadOrdinary Share
Fin del año fiscalAug 08
Dirección52 Discovery
CiudadIRVINE
Bolsa de valoresNASDAQ Global Select Consolidated
PaísUnited States of America
Código postal92618
Teléfono19492977000
Sitio Webhttps://www.masimo.com/
Código de la empresaMASI
Fecha de salida a bolsaAug 08, 2007
Fundada en1996
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bilal Muhsin
Mr. Bilal Muhsin
Chief Operating Officer
Chief Operating Officer
24.17K
+39.97%
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. William (Bill) Jellison
Mr. William (Bill) Jellison
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Mr. Micah Wesley Young
Mr. Micah Wesley Young
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
--
--
Ms. Catherine M. (Katie) Szyman
Ms. Catherine M. (Katie) Szyman
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Wendy E. Lane
Ms. Wendy E. Lane
Independent Director
Independent Director
--
--
Mr. Timothy J. (Tim) Scannell
Mr. Timothy J. (Tim) Scannell
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Bilal Muhsin
Mr. Bilal Muhsin
Chief Operating Officer
Chief Operating Officer
24.17K
+39.97%
Mr. Blair Tripodi
Mr. Blair Tripodi
Chief Operating Officer - Consumer Division
Chief Operating Officer - Consumer Division
8.61K
--
Dr. Darlene Solomon
Dr. Darlene Solomon
Independent Director
Independent Director
--
--
Mr. William (Bill) Jellison
Mr. William (Bill) Jellison
Independent Director
Independent Director
--
--
Mr. Eli Kammerman
Mr. Eli Kammerman
Investor Relations Officer
Investor Relations Officer
--
--
Mr. Quentin Koffey
Mr. Quentin Koffey
Lead Independent Vice Chairman of the Board
Lead Independent Vice Chairman of the Board
--
--
Desglose de ingresos
Divisa: USDHora de actualización: dom., 6 de abr
Divisa: USDHora de actualización: dom., 6 de abr
FY2024
FY2023
FY2022
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Sin datos
Por regiónUSD
Nombre
Ganancia
Proporción
United States
1.13B
53.84%
Europe, Middle East and Africa
595.60M
28.44%
Asia and Australia
303.50M
14.49%
North and South America (excluding the U.S.)
67.70M
3.23%
Por negocio
Por región
Sin datos
Accionista
Hora de actualización: vie., 21 de feb
Hora de actualización: vie., 21 de feb
Estadísticas de accionistas
Tipo
Estadísticas de accionistas
Accionista
Proporción
Fidelity Management & Research Company LLC
12.78%
BlackRock Institutional Trust Company, N.A.
10.25%
Politan Capital Management, L.P.
8.73%
The Vanguard Group, Inc.
8.47%
Kiani (Joe E)
7.60%
Other
52.18%
Estadísticas de accionistas
Accionista
Proporción
Fidelity Management & Research Company LLC
12.78%
BlackRock Institutional Trust Company, N.A.
10.25%
Politan Capital Management, L.P.
8.73%
The Vanguard Group, Inc.
8.47%
Kiani (Joe E)
7.60%
Other
52.18%
Tipo
Accionista
Proporción
Investment Advisor
54.35%
Investment Advisor/Hedge Fund
34.27%
Individual Investor
7.89%
Hedge Fund
6.15%
Research Firm
2.05%
Bank and Trust
1.32%
Pension Fund
1.00%
Venture Capital
0.16%
Sovereign Wealth Fund
0.14%
Participación institucional
Hora de actualización: lun., 20 de ene
Hora de actualización: lun., 20 de ene
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q1
935
58.24M
107.79%
-5.56M
2024Q4
950
56.99M
105.70%
-7.11M
2024Q3
945
55.24M
103.11%
-8.43M
2024Q2
962
54.27M
102.01%
-12.67M
2024Q1
1002
56.30M
106.05%
-9.64M
2023Q4
1090
55.26M
104.56%
-6.33M
2023Q3
1093
52.14M
98.67%
-6.57M
2023Q2
1090
50.54M
95.73%
-6.92M
2023Q1
1117
49.67M
94.09%
-7.79M
2022Q4
1136
49.92M
94.89%
-7.86M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
6.91M
12.78%
+1.20M
+20.94%
Dec 31, 2024
BlackRock Institutional Trust Company, N.A.
5.54M
10.25%
+1.43M
+34.78%
Feb 28, 2025
Politan Capital Management, L.P.
4.71M
8.73%
--
--
Dec 31, 2024
The Vanguard Group, Inc.
4.58M
8.47%
+65.93K
+1.46%
Dec 31, 2024
Kiani (Joe E)
4.04M
7.48%
-140.70K
-3.36%
Mar 03, 2025
Capital Research Global Investors
2.45M
4.54%
+1.09M
+80.47%
Dec 31, 2024
BlackRock Financial Management, Inc.
1.95M
3.61%
+51.02K
+2.69%
Dec 31, 2024
MFS Investment Management
1.73M
3.21%
+940.83K
+118.93%
Dec 31, 2024
T. Rowe Price Investment Management, Inc.
1.66M
3.08%
+135.89K
+8.90%
Dec 31, 2024
BlackRock Investment Management (UK) Ltd.
1.56M
2.89%
-163.02K
-9.45%
Dec 31, 2024
Ver más
ETFs relacionados
Hora de actualización: dom., 6 de abr
Hora de actualización: dom., 6 de abr
Nombre
Proporción
Global X Telemedicine & Digital Health ETF
4.42%
iShares Long-Term US Equity Active ETF
4.07%
Invesco Dorsey Wright Healthcare Momentum ETF
3.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
3.39%
Langar Global HealthTech ETF
3.32%
Fidelity Digital Health ETF
2.56%
Harbor Health Care ETF
2.45%
First Trust Health Care Alphadex Fund
1.98%
First Trust Indxx Medical Devices ETF
1.81%
Invesco S&P MidCap 400 Pure Growth ETF
1.67%
Ver más
Global X Telemedicine & Digital Health ETF
Proporción4.42%
iShares Long-Term US Equity Active ETF
Proporción4.07%
Invesco Dorsey Wright Healthcare Momentum ETF
Proporción3.86%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción3.39%
Langar Global HealthTech ETF
Proporción3.32%
Fidelity Digital Health ETF
Proporción2.56%
Harbor Health Care ETF
Proporción2.45%
First Trust Health Care Alphadex Fund
Proporción1.98%
First Trust Indxx Medical Devices ETF
Proporción1.81%
Invesco S&P MidCap 400 Pure Growth ETF
Proporción1.67%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos